Table 1 Baseline for the study subjects.

From: Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values

Items

L Group

M Group

H Group

N (Male/Female)

55 (37/18)

90 (56/34)

50 (36/14)

Age (Yrs)

54.09 ± 9.73

50.68 ± 9.98a*

48.40 ± 9.08a**

BMI

25.47 ± 2.91

25.34 ± 2.88

24.19 ± 3.11a*

HbA1c (%)

7.60 ± 0.32

9.13 ± 0.53

11.55 ± 1.36

Bg 0 (mmol/L)

8.53 ± 1.66

10.09 ± 1.78a**

12.40 ± 2.24ab**

Bg 30 (mmol/L)

14.69 ± 2.46

15.59 ± 2.43

18.16 ± 3.41ab**

Bg 120 (mmol/L)

18.47 ± 3.43

21.50 ± 3.75a*

24.51 ± 4.58ab*

Cp 0 (pmol/L)

2.58 ± 0.90

2.42 ± 0.82

1.81 ± 0.58ab*

Cp 30 (pmol/L)

4.40 ± 2.15

3.54 ± 1.59a*

2.50 ± 1.11ab*

Cp 120 (pmol/L)

8.10 ± 2.51

5.74 ± 2.02a*

3.72 ± 1.52ab*

Ins 0 (mU/L)

8.97 ± 4.85

8.06 ± 4.75a*

4.84 ± 2.26ab*

Ins 30 (mU/L)

24.07 ± 17.25

18.04 ± 15.69

8.44 ± 4.87ab*

Ins 120 (mU/L)

48.50 ± 26.40

28.03 ± 17.63a*

14.72 ± 10.08ab*

HOMA-IR

3.42 ± 1.87

3.69 ± 2.35

2.58 ± 1.15ab*

Matsuda Index

85.04 ± 75.47

94.63 ± 71.63

125.88 ± 59.67ab*

HOMA-B

37.81 ± 23.88

25.46 ± 15.90a**

12.01 ± 6.81ab**

  1. Data are presented as the means ± SD. L group: Lower HbA1c values group, M group: Moderate HbA1c values group, H group: higher HbA1c values group, a*compared with the L Group (P < 0.05), a**compared with M Group (P < 0.01), b*compared with M Group (P < 0.05), b**compared with M Group (P < 0.01), Bg 0: blood glucose concentrations before glucose loading, Bg 30: blood glucose concentrations at 30 min after glucose loading, Bg 120: blood glucose concentrations at 120 min after glucose loading, Cp 0: serum C-Peptide concentrations before glucose loading, Cp 30: serum C-Peptide concentrations 30 min after glucose loading, Cp 120: serum C-Peptide concentrations 120 min after glucose loading, Ins 0: serum insulin concentrations before glucose loading, Ins 30: serum insulin concentrations 30 min after glucose loading, Ins 120: serum insulin concentrations 120 min after glucose loading.